(Q37852470)

24 August 2017

1 reference

title

Diagnostic and prognostic biomarkers of sepsis in critical care (English)

1 reference

24 August 2017

0 references

0 references

0 references

Savitri Kibe

1

1 reference

24 August 2017

Kate Adams

series ordinal

2

1 reference

24 August 2017

Gavin Barlow

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Journal of Antimicrobial Chemotherapy

24 August 2017

published in

1 reference

24 August 2017

volume

66 Suppl 2

1 reference

24 August 2017

page(s)

ii33-40

1 reference

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin as a marker of the systemic inflammatory response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin leve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Activated partial thromboplastin time waveform analysis: a new tool to detect infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ523

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ523

1 reference

24 August 2017

1 reference